chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Dizziness; Fever Blister; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) and ORAL HERPES (Fever Blister) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0368218) for COVID-19 vaccination.     Concomitant products included MECLIZINE HCL and DOCOSANOL (ABREVA) for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced DIZZINESS (Dizziness) and ORAL HERPES (Fever Blister). At the time of the report, DIZZINESS (Dizziness) and ORAL HERPES (Fever Blister) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
Chilblains in second and third right toes. I experienced COVID toes with bruising and soreness for going on 2.5 months after Moderna booster. Similar reaction occured in feet after Pfizer 2nd shot.  I also experienced swollen lymph under armpits feet Moderna booster which lasted for 5-7 days after shot.
Patient received the MMR vaccine on 2/18/09.  Patient had an atypically febrile seizure on 2/25/09.  A high fever was NOT documented at the time of the seizure.  His temperature was within the normal range, taken temporally during the seizure. 3/16/09-records received for ED visit on 2/25/09 with C/O tonic cloinc generalized seizure with eyes rolled back foaming at mouth then became limp and unresponsive. Patient had URI symptoms times 1 week with temperature of 100.3 yesterday.  Observed overnight no further seizures. Assessment: Febrile seizure. Neuro consult 8/25/09-
lt arm upper part swollen, red not painful, no restriction of movements; tx benadryl, APAP
Body aches; Chills; Fever of 101; Nausea; Drymouth; extreme fatigue; Rapid heartbeat; mild headache/severe headache; Injection site pain; This is a spontaneous report from a contactable consumer (patient). A 54-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 03Feb2021, at 14:00 (at the age of 54-year-old) as a single dose for Covid-19 immunization. The patient medical history included allergies to Penicillin. Prior to the vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient concomitant medication was not reported. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine and didn't receive any other medications within 2 weeks of vaccination. On 04Feb2021, the patient had mild headache, Injection site pain. On 05Feb2021 at 11:00 the patient had severe headache, body aches, Chills, Fever of 101, Nausea, dry mouth, extreme fatigue, rapid heartbeat. It was reported that the headache subsided on 06feb2021 at 03:00 and the patient was still fatigued. The patient took Tylenol as a treatment for all the events. The seriousness of the events was reported as non- serious. The outcome of the events was reported as recovering.  Information about lot/batch number requested.
Flu like symptoms. Fever, burning up, pins and needles, aching muscles, pains in stomach, headache. Rested after burning feeling lessened. Just tired and achy the next morning. Symptoms we're experienced from approximately 9 pm until 4 am.
Initial report received from a patient who is a health care provider on Oct 14 2005. A 50 year old female patient with no pre existing medical history received in the left deltoid, an injection of Fluzone no preservation 2005 2006, lot number U1752LA, on Oct 13 2005. Within one hour, she experienced a feeling that something was stuck in her throat, a stinging sensation in her mouth and puffy and itchy eyes. She also complained of headache. The patient indicated this was her first vaccination with flu vaccine. The patient has no known allergies and takes vitamins and calcium. Illness at the time of vaccination was not specified. The next morning she was feeling better but the puffy and itchy eyes persisted. She took Claritin that am. Per the reporter, the patient was not evaluated by a physician. At the time of this report, the patient had not recovered.
About 12 mins in, right eye got real dry. A few minutes later got stuffy nose. A few minutes later, throat got dry. Throat was red but not sore. Took a Benadryl and it went ago. For Three days it was sore, had some redness below the injection site.
feeling dizzy; worried I will fall; feeling too hot; Pain in arm; body aches; A spontaneous report was received from a consumer  concerning a 36-year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced pain in arm,bodyaches,feeling dizzy,anxiety and feeling too hot. .   The patient's medical history, as provided by the reporter, included allergy to pollen. Concomitant medications reported included birth control,vitamin and Claritin for allergies to pollen.  On  11 Jan 2021  prior to the onset of the events, the patient received her first of two planned doses of mRNA-1273 (Lot number: unknown)  in the left arm for prophylaxis of COVID-19 infection.   On 11 Jan 2021 , prior to receiving mRNA-1273, the patient felt  pain in arm,bodyaches and on 12 Jan 2021 feeling dizzy,anxiety and feeling too hot. Treatment for the events was unknown. Action taken with mRNA-1273 in response to the events was not reported.   The  outcome of the events pain in arm,bodyaches,feeling dizzy,anxiety and feeling too hot was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
On 7/6, mother states she noted swelling left deltoid, redness and hot to touch. Today, 7/8/05, child returned for PPD reading. Moderate redness noted 50mmx50mm. No induration noted today. Child able to move arm with no difficulty. Mother advised to administer ice pack to area and topical Benadryl, and oral Tylenol for discomfort. Mother states S/S decreased since (Wed 7/6).
The day after (5/14) of receiving the second Pfizer dose, I developed muscle aches, fatigue, and swinging fevers.  These symptoms were resolved the next day (5/15), but that night I had an intense episode of chest pain that lasted 5-7 hours.  These symptoms went away and then returned again for a second time (5/17) around 4am for around 3-4 hours, while flying back.  I went to the hospital and had concerns from doctors over my ECG and raised troponin levels.  I spent 2 nights in the hospital and was diagnosed with Myocarditis.  This was then validated through an MRI the following day.  I am now resting at home for 3 months and taking ibuprofen.
Very sore left arm for two days after injection. Then in day 8, sudden pain and swelling of left arm bear infection site.
Pain and swelling at injection site, overall body aches, fatigue, restlessness from 04/19- 04/20 Reoccurring headaches from 04/19-Present
stating the inflammation factor in his body is 5 and a half times higher than the upper limit on the test, measuring 106; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 49-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: BLOOD DISORDER (non-serious), outcome "unknown", described as "stating the inflammation factor in his body is 5 and a half times higher than the upper limit on the test, measuring 106". Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
The patient has stomach cramps, diarrhea and sweats. The patient was treating this with Tums.
Breakthrough case admission after 2 vaccines Pfizer 3/18/21 Lot# ER2613;  Pfizer 4/8/21 lot# Ew0158
Client c/o n&v, light headed, tightening of her throat and feeling hot. IM Epi administered, paramedics called and client was transported to Hospital.
I received Moderna vaccine. First vaccination - 1/4/21. Second - 2/1/21. No significant reactions to either: no fever, chills, myalgias, fatigue, etc. However, about 1-2 weeks post the first vaccine, I developed mild distal finger joint stiffness and slight pain and swelling. Both hands. R>L. Involving 3rd - 5th fingers. Not symetrical. No other joint pains or spine pain.  There has been slight reddish soft tissue swelling  of distal phalanges  of involved fingers. Nails look normal.  Also, few punctate red spots - sl painful; they look like punctate hemorrhages. No systemic symptoms. Not requiring medication. Findings persistant till now. No involvement of toes. No generalized body rashes. I do not have psoriasis, but these findings are reminiscent of findings one would see with Psoriatic Arthritis. I am an MD (Internist). I thought this may be interesting since it looks to me like a possible immune-mediated reaction. I do have photographs available.
Baseball sized lump in the arm the evening of 12/6/2017 followed by redness, swelling and warm to touch from the shoulder down to below the elbow.
swollen; hard around the injection; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient and describes the occurrence of SWELLING (swollen) and INDURATION (hard around the injection) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWELLING (swollen) and INDURATION (hard around the injection). At the time of the report, SWELLING (swollen) and INDURATION (hard around the injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported by the reporter. No treatment medications were reported by the reporter.
After 9 years of remission of my ulcerative colitis, it flared up on 2-27-2021.  I have been in a flare for over 1 year now.  My maintenance medications stopped working and I have been dealing with moderate ulcerative colitis symptoms every single day since my 2nd vaccine. Diarrhea, bleeding, mucous, pain, gas, urgency, accidents
Immediately following the vaccine there was nausea after eating, diarrhea, and abdominal pain which lasted about 8 days. 9 days after receiving the vaccine the injection site area got itchy, hot and swollen. Redness appeared about an hour after icing the area down. Benadryl was taken within 30 minutes of symptoms starting and swelling did go down moderately, but redness and heat from area remained. Today being day 10 after the vaccine, the redness, swelling, hot temperature and itching are still present. The area is about 5 inches long and 3 inches wide. Redness is in the shape of a ring with the center of the swelling area being white and the outer edges being red. None of the symptoms have worsened since day 9 and self care with Benadryl and icing is being continued.
-Arm pain for 2 to 3 days  -Right eye bloodshot   -Menstrual period started 11 days early for the 2nd time this month. Very painful cramps and chunky discharge.
Chest pains and pressure sensation, especially in the left side of the chest. Light to mild sensations of varying intensity, waxing and waning. This went on for approximately six weeks before resolving.
Swelling and pain on i side left arm, swollen lymph nodes, armpits, side of chest. Unable to lift arm or lay left arm flat against side  due to swelling in the upper left side Torso. Injection was given in the left arm.
Severe body aches, fever, migraine  Advil and Tylenol taken. Helped a little.
upper arm injection site area was swollen; upper arm injection site area was dark red; upper arm injection site area was itchy; patient was under age 50; This case was reported by a consumer via call center representative and described the occurrence of extensive swelling of vaccinated limb in a 22-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included crohn's (Diagnosed with Crohns in 2018, about 1.5 to 2 years prior to date of reporting).   On 9th July 2019, the patient received the 1st dose of Shingrix (intramuscular). On 9th July 2019, unknown after receiving Shingrix, the patient experienced inappropriate age at vaccine administration. On an unknown date, the patient experienced extensive swelling of vaccinated limb, erythema of extremities and itchy upper limbs. On an unknown date, the outcome of the extensive swelling of vaccinated limb, erythema of extremities and itchy upper limbs were recovered/resolved and the outcome of the inappropriate age at vaccine administration was unknown.   It was unknown if the reporter considered the extensive swelling of vaccinated limb, erythema of extremities and itchy upper limbs to be related to Shingrix.  Additional details were provided as follows: The patient received 1st dose of Shingrix at an age of 22 years, which led to inappropriate age at vaccine administration. The patient experienced his whole upper arm injection site area was dark red, swollen, and itchy for quite a few days then resolved. The patient was past the 6-month window and has not received the 2nd dose of the series at the time of reporting. The reporter did not want to provide her son's MD contact information.   This case is 1 of 2 cases reported by the same reporter.
Chills, Headache, Fatigue, Injection Site Soreness (Shot 2 Only)
Fell down on the floor and died; This spontaneous case was reported by a nurse and describes the occurrence of FALL (Fell down on the floor and died) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FALL (Fell down on the floor and died) (seriousness criterion death). The patient died on 20-Aug-2021. The reported cause of death was fell on the floor and died. It is unknown if an autopsy was performed.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  The patient died yesterday after 9 days [unsure of the date] of getting the booster dose of the Moderna COVID-19 vaccine. The patient did not had any side effects with the first 2 doses of the Moderna COVID-19 Vaccine.  Treatment information was not provided.    Company Comment : Very limited information regarding the events has been provided at this time.  Further information has been requested.; Sender's Comments: Very limited information regarding the events has been provided at this time.  Further information has been requested.; Reported Cause(s) of Death: Fell on the floor and died
At 2 am the night of the vaccine, I had chills and fever 101 F. Sharp pain in left axillary.  On 6/17/21 I had swelling, aching and pain in left axillary. Today, 6/18/21 swelling is worsening and pain worsening.
52 y/o nurse who received H1N1 (Novartis) on 5/2/2010. Denies any unusual or prolonged local site reaction. Within 1 week of vaccine receipt, experienced aching pain along ribs and in back which lasted about 1 week. The following week, she experienced pain in both ankles with swelling of her feet and ankles. Foot and ankle pain and swelling lasted through Sep-Oct time frame, with gradual improvement after that. Also, around that time, she noted increased soreness of her insteps which has not yet resolved. Describes as aching sensation and "tightness" and insteps are significantly tender to palpation. Complains of similar type pain at the back of her heel. Around late May-early June, she began experiencing aching pain in her knees, followed by left hip pain, which persisted for a couple of months. At the end of May, she recalls waking up in the morning with tingling in her fingers and hands when her wrist has flexed as she pushing off bed to get up. Within a couple days, she awoke and noted drooling from the right side of her mouth and her right fingers and hand were completely numb. She was concerned that she might be having a stroke, but symptoms subsided shortly thereafter. She later experienced persistent pain in her R) hand/fingers, which was later diagnosed as trigger finger. She continues to have right hand stiffness, especially her right ring finger which sometimes locks up. Upon awakening in morning, it takes awhile to extend fingers completed and to make a tight fist. She notes her fingers loosen with activity and moist heat. Overall, this stiffness has improved a little since December 2010, but she still has tightness and aching of fingers (especially her right ring finger, which takes longer to extend than other fingers and sometimes locks). Around August, patient experienced persistent pain in her left elbow. She sought evaluation for left elbow pain and hand stiffness in August 2010 and was evaluated by Rheumatology in Sep 2010. Elbow pain located over left lateral epicondyle and radiates to promixal forearm. Exam showed no active synovitis of hand joints, with minimal swelling and tenderness of left epicondyle, without warmth, bursa swelling or tophus; exam of knees revealed FROM, without tenderness; hips with FROM, without point tenderness; and no lower extremity edema. She was diagnosed with "arthralgias, rule out reactive arthritis" and treated with naproxen and capsaicin cream applied to left elbow. At Rheumatology follow-up in Dec 2010, exam noted to active synovitis; pain over left lateral epicondyle, worse with left wrist extension and supination. Painful nodule over right 4th flexor tendon had improved. Assessment noted improvement of left elbow pain with capsaicin cream and also noted morning stiffness in right hand: no evidence of synovitis or inflammatory arthritis on x-rays or labs; follow up 3 months. Patient reports intermittent discoloration of knuckles, as well as intermittent paresthesias described as burning pain along medial and lateral sides of calves about 2-4 times per month, lasting for less than 1 hour. Dx: Reactive arthritis.
Forgot the third dose until day 6 and wanted to take their fourth dose on the same day as well; Spontaneous report received on 26DEC2019.  A pharmacist reported that a 65-year-old consumer "forgot the third dose until day 6 and wanted to take their fourth dose on the same day as well" (PT: Inappropriate schedule of product administration) while being on Vivotif for immunisation. The consumer took the first and second dose of Vivotif on 21DEC2019 and 23DEC2019 respectively, but forgot to take the third dose as per schedule. The consumer took the third dose on 26DEC2019 at 4 am and wanted to take their fourth dose on the same day as well. Action taken with Vivotif with respect to the reported event was not applicable. The outcome of the reported event was unknown.  Company Comment: A consumer took first two doses of Vivotif as per the schedule and forgot to take the third dose until day 6 and wanted to take fourth dose on the same day as well (Inappropriate schedule of vaccine administered). The causality of the event is assessed as not related to Vivotif due to the nature of the event.; Sender's Comments: A consumer took first two doses of Vivotif as per the schedule and forgot to take the third dose until day 6 and wanted to take fourth dose on the same day as well (Inappropriate schedule of vaccine administered). The causality of the event is assessed as not related to Vivotif due to the nature of the event.
Significant rash/allergy reaction to head, face and neck without airway obstruction - no improvement with home Benadryl
Temp 101.8 7/6/04 (Inoculated for yellow fever on 07/01/04) x2days Body ache, Headache- Pain level 9 on 1-10 scale Sore throat, throat swollen (7/1/04 fever decreased feeling better)
Patient had anaphylactic reaction. Within 12 hours patient had hives on legs, arms, chest, throat had been closing. Patient had already felt she may genetically at risk for an adverse outcome. She premedicated with Nurtec and Benadryl. She took more Benadryl with the onset of the reaction.
itchy rash all over her body starting on 6/19/2023; This spontaneous report was received from patient's daughter and refers to a 63-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions included Sjogren's syndrome. The patient's doctor did bloodwork to check her immune system and the results showed that her immune system was "practically nonexistent ". The patient had none drug reactions/allergies. Concomitant medications included multi vitamin, low dose of prednisone and unspecified thyroid medication.   On 15-JUN-2023, the patient started therapy with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, (dose, anatomical location, lot #, expiry date, and route of administration were not provided) administered for prophylaxis (also reported as "to check for antibodies" and "see if she was able to build antibodies"). The doctor planned to do follow-up bloodwork in a few weeks to test for antibodies. The patient received the vaccine from her primary care doctor, but her immunologist prescribed it.  On 19-JUN-2023 (also reported "a few days after receiving pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23)"), the patient experienced itchy rash all over her body. The patient called her doctor regarding this and the doctor sent her a topical antihistamine cream to use. The patient also reported that when she developed the rash, her doctor was not in so she went to the emergency room (no further details provided by the caller). The patient began using the cream on 22-JUN-2023, but as of 23-JUN-2023 did not felt any relief. The patient's daughter who was the reporter was concerned because she had read that a rash was a serious side effect of the pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23). At the time of reporting, the patient had not recovered from the event.  The causal relationship between the event and pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was not reported.